Aker BioMarine AS

OB:AKBM Stock Report

Market Cap: NOK 5.0b

Aker BioMarine Management

Management criteria checks 3/4

Aker BioMarine's CEO is Matts Johansen, appointed in Jul 2015, has a tenure of 9.33 years. total yearly compensation is $688.81K, comprised of 61% salary and 39% bonuses, including company stock and options. directly owns 1.25% of the company’s shares, worth NOK62.52M. The average tenure of the management team and the board of directors is 3.2 years and 3.7 years respectively.

Key information

Matts Johansen

Chief executive officer

US$688.8k

Total compensation

CEO salary percentage61.0%
CEO tenure9.3yrs
CEO ownership1.2%
Management average tenure3.2yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 08
Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

Nov 05
Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20
At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

Jul 19
Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Jul 16
What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Jul 11
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

Jun 03
These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

Feb 15
There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Nov 06
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Sep 06
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Nov 04
We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Apr 13
Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Feb 18
Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Jan 07
Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

CEO Compensation Analysis

How has Matts Johansen's remuneration changed compared to Aker BioMarine's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$3m

Jun 30 2024n/an/a

-US$11m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$689kUS$420k

-US$9m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$300k

Mar 31 2023n/an/a

US$14m

Dec 31 2022US$410kUS$401k

US$10m

Sep 30 2022n/an/a

US$1m

Jun 30 2022n/an/a

US$10m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$467kUS$459k

-US$8m

Sep 30 2021n/an/a

US$3m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$630kUS$420k

-US$5m

Sep 30 2020n/an/a

-US$26m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$660kUS$450k

-US$24m

Compensation vs Market: Matts's total compensation ($USD688.81K) is above average for companies of similar size in the Norwegian market ($USD472.54K).

Compensation vs Earnings: Matts's compensation has been consistent with company performance over the past year.

CEO

Matts Johansen (48 yo)

9.3yrs

Tenure

US$688,813

Compensation

Mr. Matts Johansen has been Chief Executive Officer at Aker BioMarine ASA since July 1, 2015. Mr. Johansen has been Chief Operating Officer of Aker Biomarine Antarctic AS since June 1, 2012. He serves as P...

Leadership Team

NamePositionTenureCompensationOwnership
Matts Johansen
Chief Executive Officer9.3yrsUS$688.81k1.25%
NOK 62.5m
Katrine Klaveness
Chief Financial Officer6.8yrsUS$378.29kno data
Hege Spaun
Chief Officer People & Communicationless than a yearUS$221.24kno data
Trond Smedsrud
Chief Executive Officer of Emerging Businessno dataUS$284.93kno data
Tone Lorentzen
Chief Operating Officer of Human Health Ingredientsno dataUS$339.88kno data
Simon Seward
Chief Executive Officer of Human Health Ingredients2.8yrsUS$306.31kno data
Seth French
Chief Executive Officer of Lang Pharma Nutrition Inc3.2yrsUS$834.94kno data
Christopher Robin Vinter
Vice President of IR & Corporate Financeno datano datano data
Lise Wiger
Financial Controllerno datano datano data

3.2yrs

Average Tenure

Experienced Management: AKBM's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kjell Røkke
Deputy Directorno datano datano data
Frank Reite
Directorno dataUS$30.76kno data
Anne Harris
Independent Director3.7yrsUS$48.75kno data
Ola Snøve
Chairman10.8yrsUS$70.05k0.98%
NOK 49.0m
Cilia Indahl
Director3.7yrsUS$30.76kno data
Sindre Skjong
Employee Representative Director5.3yrsno datano data
Kimberly Mathisen
Director2.6yrsUS$30.76kno data
Kristin Holmgren
Employee Representative Director1.4yrsno data0.0040%
NOK 197.8k
Thomas Rokke
Employee Representative Director1.4yrsno datano data

3.7yrs

Average Tenure

53yo

Average Age

Experienced Board: AKBM's board of directors are considered experienced (3.7 years average tenure).